[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Waid City Hospital, Zurich\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100635639","clinical-experience-with-sparsentan-in-switzerland-in-iga-nephropathy-100635639",false,"NCT07555301","Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy","SWIAN","Inclusion Criteria:\n\n* IgA Nephropathy, Use of Sparsentan\n\nExclusion Criteria:\n\n* age \\\u003C 18y","ALL","18 Years",{"count":19,"type":20},50,"ESTIMATED","OBSERVATIONAL","An observational study tracking the clinical course of patients with IgA nephropathy.",[24],"IgA Nephropathy (IgAN)","NOT_YET_RECRUITING","2026-04-21",{"date":28,"type":29},"2026-04-29","ACTUAL",{"date":31,"type":20},"2026-06-01",{"date":33,"type":20},"2029-12-31",{"name":35,"class":36},"Waid City Hospital, Zurich","OTHER",""]